Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.360 | Biomarker | disease | BEFREE | Fluctuations in prothrombin time and the patient's clinical status should be considered even in the event of severe liver failure. | 30521841 | 2019 | ||||
|
0.360 | Biomarker | disease | BEFREE | No correlations were observed between KGR<sub>PVE</sub> or KGR<sub>POD7</sub> and serum total bilirubin and prothrombin time - international normalized ratio on POD 7, nor in the incidence of liver failure after surgery. | 31117157 | 2019 | ||||
|
0.360 | AlteredExpression | disease | BEFREE | In addition, liver function and prothrombin activity were detected, and ultrasonography was performed.The GD score was significantly higher in the LF groups than in the control group. | 30508896 | 2018 | ||||
|
0.360 | Biomarker | disease | BEFREE | In patients with a high prothrombin time-international normalized ratio to albumin ratio, pathologic liver cirrhosis (P < .001), postoperative ascites (P = .039), and postoperative liver failure (P = .040) were greater than for their counterparts. | 29754978 | 2018 | ||||
|
0.360 | Biomarker | disease | BEFREE | Prothrombin time on postoperative day 5 (PT5), ISGLS, and Clavien-Dindo were found to have significant correlation with the prognosis of PHLF (<i>r</i>>0.5, <i>p</i> <0.05), thus can be used as prognosis predictors for PHLF patients. | 29179518 | 2017 | ||||
|
0.360 | Biomarker | disease | CTD_human | Patients (n = 47) with reactivated hepatitis due to lamivudine-resistant HBV were classified into two groups, with and without potential for progression to hepatic failure, according to the criteria using the data of serum bilirubin level and prothrombin activity after the reactivated hepatitis. | 18618250 | 2008 | ||||
|
0.360 | GeneticVariation | disease | BEFREE | The laboratory data revealed HBV reactivation and liver failure (ALT: 1828 IU/L, total bilirubin: 10 mg/dL, and prothrombin INR: 3.24). | 15162553 | 2004 |